Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check3 days agoChange DetectedAdded the Dimopoulos et al. 2007 NEJM article to Publications. Removed the Erratum for that article (2009) from the References.SummaryDifference0.0%
- Check10 days agoChange DetectedRemoved the Multiple myeloma topic and related resources, including MedlinePlus Genetics, from the page's topics/related resources.SummaryDifference0.1%
- Check17 days agoChange DetectedAdded related topics for Multiple Myeloma and MedlinePlus Genetics, including the International uniform response criteria citation. Updated the revision to v3.5.0 and removed the older Leukemia 2006 erratum reference.SummaryDifference0.2%
- Check24 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%
- Check31 days agoChange DetectedA bibliographic reference (Dimopoulos et al., 2007 NEJM) was added and then removed in the Publications section.SummaryDifference0.0%
- Check39 days agoChange DetectedTwo bibliographic references were added and two related topic tags were removed from the study page.SummaryDifference0.2%
Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.